World Economic Forum finds no evidence of wrongdoing by founder Klaus SchwabThe World Economic Forum's board concluded an investigation into Klaus Schwab, finding no evidence of material wrongdoing. This followed a ...
How an LGBTQ+ cafe's neon sign became a beacon for hate in BerlinA cafe in Berlin, a safe space for LGBTQ+ people, faces increasing hate crimes. Verbal and physical assaults are common. There is a rise in...
Favre Leuba eyes India as key market for global comeback, partners with Ethos for exclusive retailFavre Leuba, the world's second oldest watch brand, is making a comeback with India expected to be its biggest market. Chairman Patrik Hoff...
Supreme Court asks Zydus Lifesciences to approach Delhi HC over ban on selling breast cancer drug SigrimaThe Supreme Court has instructed Zydus Lifesciences to approach the Delhi High Court. Zydus is seeking relief from an order that prevents t...
Delhi HC allows Zydus Lifesciences to sell breast cancer drug SigrimaThe Delhi High Court division bench has allowed Zydus Lifesciences to sell its breast cancer drug Sigrima amidst accusations of it being si...
Poker Face Season 2: Check out exciting updates about cast and production teamSeason 2 of "Poker Face" on Peacock adds Giancarlo Esposito, Katie Holmes, Kumail Nanjiani, and Gaby Hoffmann to its guest cast. The show, ...
'Eric': This is what we know so far about plot, cast, production, release date, streaming platform and episode count'Eric,' a new Netflix series by Abi Morgan, stars Benedict Cumberbatch as Vincent, a father searching for his missing son in 1980s New York...
Sun Pharma names Aalok Shanghvi as whole-time directorSun Pharma Board has appointed Aalok Shanghvi as a whole-time director for a five-year term beginning June 1, 2023. Shanghvi, the son of Su...
Omicron variant resistant to antibodies, two vaccine doses: StudyHowever, the study found that a third dose of the Pfizer vaccine, and mixing Pfizer and AstraZeneca preventives may protect well against th...
Kotak Institutional Equities retains sell on Bayer Cropscience, target price raised to Rs 3,000Expensive valuations at 37 times FY21 estimated EPS reflect a heightened growth expectation, said Kotak.
Hoffmann Group appoints Manav Goel as India DirectorGoel will be responsible for driving the group's sales and strategic business partnerships in India, Hoffman said in a statement.
Natco Pharma surges 7% on drug approvalThe stock rose 7.33 per cent to hit a high of Rs 650.90 on BSE. Volumes more than doubled on the counter to 98,000 shares, compared with a ...
Natco Pharma gets ANDA nod for Tamiflu's generic versionTamiflu is used to treat the flu (influenza) in people 2 weeks of age and older who have had flu symptoms for no more than 2 days.
Natco settles patent suit with Gilead, others over TamifluNatco Pharma and its partner Alvogen today said they have settled patent infringement suit with Gilead Sciences Inc and others over Tamiflu.
Intas settles patent litigation with Hoffmann-La Roche for capecitabine tabletAhmedabad-based drug maker, Intas Pharmaceuticals Ltd and its US-based wholly owned subsidiary Accord Healthcare Inc. has entered into a se...
- Pharma companies donate tamiflu
The Indian arm of Swiss pharma major Hoffmann-La Roche and Hyderabad-based Hetero Drugs have together donated one lakh dosages of Tamiflu m...
- Delhi HC refuses relief to Swiss Company La Roche against Cipla
The Delhi High Court has refused to grant relief to Swiss pharma company Hoffmann La Roche, which sought restraining Cipla from manufacturi...